Studying DNA changes and biological age in preventing chronic diseases in Kazakhstan
Examines DNA analysis and biological age in adults at risk of chronic diseases.
Plain-language title generated from the registry record
Registry title: Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Key facts
- Where
- Almaty, KazakhstanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 69 years old?
Source: NCT06953180, who can take part
Where in Kazakhstan
- Asfendiyarov Kazakh National Medical UniversityAlmaty, KazakhstanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Asfendiyarov Kazakh National Medical University
- Trial code
- NCT06953180
- Record updated
- 11 July 2025
- Original description
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.Read full original descriptionShow less
Epigenetics and Prevention of Non-communicable Diseases in Kazakhstan: a Personalized Approach and Biological Age Prediction
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.
Inclusion: Adults aged 18 to 69 years; Residents of 17 regions of Kazakhstan; Willingness to participate and provide informed consent.
Exclusion: Failure to provide informed consent or incomplete participation in data collection procedures; Age less than 18 years old or over 69 years old.